Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Diet can help manage equine gastric ulcer syndrome - study
Dietary and management changes are often recommended to help cut the risk of EGUS.

Research assess effect of diet change on omeprazole

A new study has confirmed that a suitable diet can help manage equine gastric ulcer syndrome (EGUS).

The research, presented at the International Colic Symposium (July 20), found that a change in diet was able to maintain the beneficial effect of pharmaceutical treatment, even after treatment had finished.

The research was conducted by researchers in Denmark, Madrid and Glasgow, in collaboration with SPILLARS and the WALTHAM Equine Studies Group.

Clare Barfoot, research and development manager at SPILLERS, commented: “This exciting work confirms what we suspected; that whilst appropriate dietary change can provide additional support to medical treatment for EGUS most importantly it can help maintain better gastric health post medical treatment.”

EGUS can affect any horse and refers to the ulceration of the animal’s stomach lining. Several factors, including nutrition, have been proven to raise the risk of ulcers occurring, particularly in the non-glandular part of the stomach.

Dietary and management changes are often recommended to help cut the risk of EGUS and are often recommended for use in conjunction with pharmaceutical treatment. Until now, however, there has been little research to confirm their benefit under such circumstances.

In the study, researchers assessed the effect of dietary change in combination with pharmaceutical treatment (omeprazole) and after the treatment had finished. The 32 horses used in the trial had been diagnosed with significant equine squamous gastric disease (ESGD) and were in hard work.

The horses were paired according to their workload and severity of their ulcers. One of each pair was randomly assigned to a specified low starch, fibre-based diet while the other stayed on their original diet. All animals were scoped before, after the recommended course of omeprazole treatment and then six weeks after the omeprazole finished.

Researchers found that horses on their original diet improved significantly with the omeprazole but when the treatment was stopped many regressed. Overall, by the end of the trial they were not significantly different to when they had started.

However, the horses whose diet had changed showed significant improvement, not only following the omeprazole treatment but also after the treatment had stopped. This showed that a change in diet was able to help maintain the beneficial effect of omeprazole, even after it was removed.

The study achieved an award in 2016 for research in horse welfare from the Fundación para la Promoción del Deporte Ecuestre, Spain.

Image (C) Nanna Luthersson.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.